# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-015178
Filing Date
2025-04-23
Accepted
2025-04-23 16:03:09
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA 14A | ny20043084x2_defa14a.htm | DEFA14A | 7846
2 |  | ny20043084x2_defa14a-nc01.jpg | GRAPHIC | 526137
3 |  | ny20043084x2_defa14a-nc02.jpg | GRAPHIC | 380410
| Complete submission text file | 0001140361-25-015178.txt |  | 1257062

Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39402 | Film No.: 25861355
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)